✦ LIBER ✦

High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study

✍ Scribed by Marianne B. Eide; Grete F. Lauritzsen; Gunnar Kvalheim; Arne Kolstad; Unn M. Fagerli; Martin Maisenhölder; Bjørn Østenstad; Øystein Fluge; Jan Delabie; Harald Aarset; Knut Liestøl; Harald Holte

Book ID: 108677101
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 247 KB
Volume: 152
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08519.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with carboplatin,

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study

✍ Kleiner, S; Kirsch, A; Schwaner, I; Kingreen, D; Schwella, N; Huhn, D; Siegert, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Standard chemotherapy is superior to hig

Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis

✍ Jing Wang; Ping Zhan; Jian Ouyang; Bing Chen; Rongfu Zhou; Yonggong Yang 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 219 KB

A phase II study of two cycles of high-d

A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle

✍ Bashey, A; Corringham, S; Garrett, J; Lane, T A; Gilpin, E A; Corringham, R E T; 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

High-dose melphalan with autologous stem

High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study

✍ Jolanta B. Perz; Stefan O. Schonland; Michael Hundemer; Arnt V. Kristen; Thomas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

High-dose chemotherapy with autologous s

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

✍ Colombat, Ph; Lemevel, A; Bertrand, P; Delwail, V; Rachieru, P; Brion, A; Bertho 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Phase II study of a salvage regimen usin

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB